Biomet has been purchased by rival manufacturer Zimmer for $14 billion, despite both companies facing hip replacement lawsuits for their orthopedic devices. Both companies are based out of Warsaw, Indiana, where Biomet made its M2a Magnum metal-on-metal hip replacement.
Biomet hip replacement lawsuits are expected to continue regardless of the acquisition, as patients continue to file complaints alleging that the M2a Magnum hip implants caused serious injuries. A medical study published in 2011 found that 7.2% of patients who received an M2a Magnum required revision surgery within the first year.
Metal-on-metal hip replacement side effects have plagued patients since the devices’ inception. Patients who received a Biomet M2a Magnum hip have complained of metallosis, premature loosening of the hip implant, tissue damage, pain, fretting, corrosion and limited mobility.